Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   168,823    

Indirect Shares

  417,826      
Direct Value   $5,035,310    

Indirect Value

  $13,780,226      
Total Shares   586,649      
Total Value   $18,815,536      


Agios Pharmaceuticals Inc
 $4,464,514 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,172 Denali Therapeutics Inc.
 $288,218 Regeneron Pharmaceuticals Inc
 $276,405 Agios Pharmaceuticals Inc
 $4,464,514 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,172 Denali Therapeutics Inc.
 $288,218 Regeneron Pharmaceuticals Inc
 $276,405
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    3    

     Stock price went up :

    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 35.8%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2023-06-01 15,529 2023-06-01 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    153         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-01 4 OE $0.30 $3,933 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-24 4 OE $0.30 $4,094 D/D 13,533 13,533 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2016-01-07 4 OE $0.30 $6,050 I/I 20,000 272,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-06-01 4 OE $0.47 $6,280 D/D 13,000 13,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-26 4 OE $0.30 $7,131 D/D 23,572 23,572 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-02 4 OE $0.30 $7,260 D/D 24,000 24,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-03-25 4 OE $0.30 $7,563 I/I 25,000 266,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-27 4 OE $0.30 $7,563 I/I 25,000 248,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-26 4 OE $0.30 $9,075 I/I 30,000 283,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-23 4 OE $0.30 $9,945 D/D 32,875 32,875 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-18 4 OE $0.30 $10,588 D/D 35,000 35,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-23 4 OE $0.30 $14,936 D/D 49,374 49,374 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-01-16 4 OE $0.30 $16,033 D/D 53,000 53,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-03-10 4 OE $0.30 $16,335 I/I 54,000 241,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2018-05-30 4 OE $0.30 $17,675 D/D 45,626 45,626 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2022-02-22 4 D $29.08 $22,043 D/D (758) 116,294 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-10-04 4 OE $0.30 $24,200 D/D 80,000 80,000 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2020-02-24 4 D $48.66 $42,821 D/D (880) 105,053 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-06 4 AS $50.02 $55,022 D/D (1,100) 0 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-13 4 AS $120.31 $82,292 I/I (684) 106,401 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-11 4 AS $120.14 $94,550 I/I (787) 107,085 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-07 4 AS $50.02 $95,038 D/D (1,900) 0 0 -
BLUE Bluebird Bio, Inc. Director   –       •      –    2014-12-19 4 B $85.00 $99,960 D/D 1,176 1,176 2.39 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-10-27 4 OE $31.64 $126,560 I/I 4,000 236,272 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2020-02-18 4 D $52.01 $131,793 D/D (2,534) 103,158 0 -

  153  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed